126 related articles for article (PubMed ID: 10442745)
1. Studies on smaller (approximately 315 microM) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules.
Leblond FA; Simard G; Henley N; Rocheleau B; Huet PM; Hallé JP
Cell Transplant; 1999; 8(3):327-37. PubMed ID: 10442745
[TBL] [Abstract][Full Text] [Related]
2. Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. III. Biocompatibility Of smaller versus standard microcapsules.
Robitaille R; Pariseau JF; Leblond FA; Lamoureux M; Lepage Y; Hallé JP
J Biomed Mater Res; 1999 Jan; 44(1):116-20. PubMed ID: 10397911
[TBL] [Abstract][Full Text] [Related]
3. Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties.
Strand BL; Gåserød O; Kulseng B; Espevik T; Skjåk-Baek G
J Microencapsul; 2002; 19(5):615-30. PubMed ID: 12433304
[TBL] [Abstract][Full Text] [Related]
4. Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. V. Determination of carbohydrate and protein permeation through microcapsules by reverse-size exclusion chromatography.
Robitaille R; Leblond FA; Bourgeois Y; Henley N; Loignon M; Hallé JP
J Biomed Mater Res; 2000 Jun; 50(3):420-7. PubMed ID: 10737885
[TBL] [Abstract][Full Text] [Related]
5. Intra-portal injection of 400- microm microcapsules in a large-animal model.
Toso C; Oberholzer J; Ceausoglu I; Ris F; Rochat B; Rehor A; Bucher P; Wandrey C; Schuldt U; Belenger J; Bosco D; Morel P; Hunkeler D
Transpl Int; 2003 Jun; 16(6):405-10. PubMed ID: 12819871
[TBL] [Abstract][Full Text] [Related]
6. [Study on cytomedicine of alginate-poly(L) lysine-alginate microencapsulated hybridoma cells].
Zhao DJ; Jin Y; Fu HX; Chen P
Yao Xue Xue Bao; 2004 Aug; 39(8):635-9. PubMed ID: 15563068
[TBL] [Abstract][Full Text] [Related]
7. Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-L-lysine membranes.
Hallé JP; Bourassa S; Leblond FA; Chevalier S; Beaudry M; Chapdelaine A; Cousineau S; Saintonge J; Yale JF
Transplantation; 1993 Feb; 55(2):350-4. PubMed ID: 8434387
[TBL] [Abstract][Full Text] [Related]
8. The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection.
Wong H; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):675-86. PubMed ID: 1810402
[TBL] [Abstract][Full Text] [Related]
9. Membrane compactness affects the integrity and immunoprotection of alginate-poly-L-lysine-alginate microcapsules.
Hsu BR; Ho YS; Fu SH; Huang YY; Chiou SC; Huang HS
Transplant Proc; 1995 Dec; 27(6):3227-31. PubMed ID: 8539927
[No Abstract] [Full Text] [Related]
10. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics.
Koch S; Schwinger C; Kressler J; Heinzen Ch; Rainov NG
J Microencapsul; 2003; 20(3):303-16. PubMed ID: 12881112
[TBL] [Abstract][Full Text] [Related]
11. Time course of transforming growth factor-beta(1) (TGF-beta(1)) mRNA expression in the host reaction to alginate-poly-L-lysine microcapsules following implantations into rat epididymal fat pads.
Robitaille R; Desbiens K; Henley N; Hallé JP
J Biomed Mater Res; 2000 Oct; 52(1):18-23. PubMed ID: 10906670
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Poly-L-Ornithine-coated alginate microcapsules.
Darrabie MD; Kendall WF; Opara EC
Biomaterials; 2005 Dec; 26(34):6846-52. PubMed ID: 15955558
[TBL] [Abstract][Full Text] [Related]
13. Type 1 Diabetes Mellitus reversal via implantation of magnetically purified microencapsulated pseudoislets.
Espona-Noguera A; Etxebarria-Elezgarai J; Saenz Del Burgo L; Cañibano-Hernández A; Gurruchaga H; Blanco FJ; Orive G; Hernández RM; Benito-Lopez F; Ciriza J; Basabe-Desmonts L; Pedraz JL
Int J Pharm; 2019 Apr; 560():65-77. PubMed ID: 30742984
[TBL] [Abstract][Full Text] [Related]
14. Effective removal of alginate-poly-L-lysine microcapsules from pancreatic islets by use of trypsin-EDTA.
de Groot M; Leuvenink HG; Keizer PP; Fekken S; Schuurs TA; van Schilfgaarde R
J Biomed Mater Res A; 2003 Nov; 67(2):679-83. PubMed ID: 14566813
[TBL] [Abstract][Full Text] [Related]
15. Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules.
Fu HX; Li H; Wu LL; Zhao YZ; Xu YY; Zhu YL; Xue SL; Wang DW; Liu CY; Yang SL; Li XK
Drug Dev Ind Pharm; 2014 Nov; 40(11):1523-9. PubMed ID: 24564824
[TBL] [Abstract][Full Text] [Related]
16. Adsorption of human immunoglobulin to implantable alginate-poly-L-lysine microcapsules: effect of microcapsule composition.
Tam SK; de Haan BJ; Faas MM; Hallé JP; Yahia L; de Vos P
J Biomed Mater Res A; 2009 Jun; 89(3):609-15. PubMed ID: 18435412
[TBL] [Abstract][Full Text] [Related]
17. Macroaggregated albumin potentiates the hypoglycemic effect of microencapsulated islets in the fed state of streptozotocin-induced diabetic mice.
Hsu BR; Fu SH; Huang YY; Hsu AW; Chuang KL; Huang HS
J Microencapsul; 1997; 14(1):27-34. PubMed ID: 8994073
[TBL] [Abstract][Full Text] [Related]
18. Deterioration of polyamino acid-coated alginate microcapsules in vivo.
van Raamsdonk JM; Cornelius RM; Brash JL; Chang PL
J Biomater Sci Polym Ed; 2002; 13(8):863-84. PubMed ID: 12463508
[TBL] [Abstract][Full Text] [Related]
19. [Theoretical calculation and experimental study of membrane thickness of alginate-(poly-L-lysine)-alginate microcapsules].
Sun D; Chen Y; Yang J; Su J; Sun AM
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):645-7, 656. PubMed ID: 12561369
[TBL] [Abstract][Full Text] [Related]
20. Xenotransplantation of exendin-4 gene transduced pancreatic islets using multi-component (alginate, poly-L-lysine, and polyethylene glycol) microcapsules for the treatment of type 1 diabetes mellitus.
Park JB; Jeong JH; Lee M; Lee DY; Byun Y
J Biomater Sci Polym Ed; 2013; 24(18):2045-57. PubMed ID: 23905775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
